Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PALLADIUM: QMF149 vs Mometasone and Salmeterol/Fluticasone in Asthma
NCT02554786Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2015
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
- Countries
- 24
01
Overview
A Phase 3 trial of atectura breezhaler in asthma, sponsored by Novartis. Started Dec 2015; status: completed.
02
Drugs
atectura breezhaler
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02554786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554786.